Literature DB >> 29777762

Astrocyte elevated gene-1 is a novel regulator of astrogliosis and excitatory amino acid transporter-2 via interplaying with nuclear factor-κB signaling in astrocytes from amyotrophic lateral sclerosis mouse model with hSOD1G93A mutation.

Xiang Yin1, Shuyu Wang2, Yan Qi2, Xudong Wang2, Hongquan Jiang2, Tianhang Wang2, Yueqing Yang2, Ying Wang2, Chunting Zhang2, Honglin Feng3.   

Abstract

AEG-1 has received extensive attention on cancer research. However, little is known about its roles in astrogliosis of Amyotrophic lateral sclerosis (ALS). In this study, we detected AEG-1 expression in hSOD1G93A-positive (mut-SOD1) astrocytes and wild type (wt-SOD1) astrocytes, and intend to elucidate its potential functions in ALS related astrogliosis and the always accompanied dysregulated glutamate clearance. Results showed elevated protein and mRNA levels of AEG-1 in mut-SOD1 astrocytes; Also, NF-κB signaling pathway related proteins and inflammatory cytokines were upregulated in mut-SOD1 astrocytes; AEG-1 knockdown attenuated astrocytes proliferation and pro-inflammatory release; also we found that AEG-1 silence inhibited translocation of p65 from cytoplasma to nuclear, which was associated with inhibited NF-κB signaling. Besides, excitatory amino acid transporter-2 (EAAT2) expression levels were significantly decreased, accompanied by impaired glutamate clearance ability, in mut-SOD1 astrocytes; yin yang 1 (YY1), a transcriptional inhibitor for EAAT2, increased in nucleus of mut-SOD1 astrocytes. AEG-1 silence inhibited translocation of YY1 to nucleus, increased EAAT2 expression levels, and enhanced astrocytic ability of glutamate clearance, ultimately exerted the neuronal protection. Findings from this study implicate potential function of AEG-1 in mut-SOD1 related astrogliosis and the accompanied excitatory cytotoxic mechanism in ALS.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis (ALS); Astrocyte elevated gene-1 (AEG-1); Astrocytes; NF-κB pathway; Neurodegeneration

Year:  2018        PMID: 29777762     DOI: 10.1016/j.mcn.2018.05.004

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  5 in total

Review 1.  The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.

Authors:  Edward Pajarillo; Asha Rizor; Jayden Lee; Michael Aschner; Eunsook Lee
Journal:  Neuropharmacology       Date:  2019-03-06       Impact factor: 5.250

2.  Astrocyte-specific deletion of the transcription factor Yin Yang 1 in murine substantia nigra mitigates manganese-induced dopaminergic neurotoxicity.

Authors:  Edward Pajarillo; James Johnson; Asha Rizor; Ivan Nyarko-Danquah; Getinet Adinew; Julia Bornhorst; Michael Stiboller; Tania Schwerdtle; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  J Biol Chem       Date:  2020-09-06       Impact factor: 5.157

3.  Neurotoxicity mechanisms of manganese in the central nervous system.

Authors:  Edward Pajarillo; Ivan Nyarko-Danquah; Getinet Adinew; Asha Rizor; Michael Aschner; Eunsook Lee
Journal:  Adv Neurotoxicol       Date:  2021-01-27

4.  Genetic targeting of astrocytes to combat neurodegenerative disease.

Authors:  Rachel Kery; Allen P F Chen; Gregory W Kirschen
Journal:  Neural Regen Res       Date:  2020-02       Impact factor: 5.135

5.  Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice.

Authors:  Oluwamolakun Bankole; Ilaria Scambi; Edoardo Parrella; Matilde Muccilli; Roberta Bonafede; Ermanna Turano; Marina Pizzi; Raffaella Mariotti
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.